Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
阿里斯托芬政治谐剧中的自然哲学
Aliskiren Prevents the Toxic Effects of Peritoneal Dialysis Fluids during Chronic Dialysis in Rats
Aliskiren, at low doses, reduces the electrical remodeling in the heart of the TGR(mRen2)27 rat independently of blood pressure
Alistipes indistinctus sp nov and Odoribacter laneus sp nov., common members of the human intestinal microbiota isolated from faeces
Aliskiren affects fatty-acid uptake and lipid-related genes in rodent and human cardiomyocytes
Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy
Alisma plantago-aquatica L.: the cytoskeleton of the suspensor development
Aliskiren reduces portal pressure and intrahepatic resistance in biliary cirrhotic rats
Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats
Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice
Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats
Aliskiren in an alternate-day administration schedule in hypertensive albuminuric patients
Aliskiren Alone or in Combination With Hydrochlorothiazide in Hispanic/Latino Patients With Systolic Blood Pressure 160 mm Hg to < 180 mm Hg (Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] Substudy)
Alisporivir for the treatment of chronic HCV
Aliskiren and losartan trial in non-diabetic chronic kidney disease
Aliskiren/Amlodipine Single-Pill Combinations: More Evidence in Favour of Combination Formulations for the Treatment of Hypertension
Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases
Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
Aliskiren, the first direct renin inhibitor for treatment of hypertension: The path of its development
Aliskiren: the first direct renin inhibitor available for clinical use
Aliskiren-based stepped-care treatment algorithm provides effective blood pressure control
Aliskiren A Review of its Use as Monotherapy and as Combination Therapy in the Management of Hypertension
Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial
Aliskiren in the Treatment of Hypertension and Organ Damage
Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production
Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury
Alisertib (MLN8237), a selective Aurora-A kinase inhibitor, induces apoptosis in human tongue squamous cell carcinoma cell both in vitro and in vivo
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension
Aliskiren Fails to Lower Blood Pressure in Patients Who Have Either Low PRA Levels or Whose PRA Falls Insufficiently or Reactively Rises
Aliskiren: An Oral Direct Renin Inhibitor for the Treatment of Hypertension
Alishewanella tabrizica sp nov., isolated from Qurugol Lake
Aliskiren - mode of action and preclinical data
Aliskiren, exendin-4, and insulin: their impact on endothelin receptor subtype(s) regulation/binding in type 1 diabetic rat hearts
Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection
Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial
Aliskiren and Perindopril Reduce the Levels of Transforming Growth Factor-beta in Patients With Non-Diabetic Kidney Disease
Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study
Aliskiren
Aliskiren improves nitric oxide Bioavailability and limits atherosclerosis
Aliskiren an oral direct renin inhibitor
Aliskiren penetrates adipose and skeletalmuscle tissue and reduces renin-angiotensin system activity in obese hypertensive patients
Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation
Alistair M. Hetherington
Alisertib induces G(2)/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells
Aliskiren protects against myocardial ischaemia-reperfusion injury via an endothelial nitric oxide synthase dependent manner
Alismol, a Sesquiterpenoid Isolated from Vladimiria souliei, Suppresses Proinflammatory Mediators in Lipopolysaccharide-Stimulated Microglia
Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model
Alisol B, a triterpene from Alismatis rhizoma (dried rhizome of Alisma orientale), inhibits melanin production in murine B16 melanoma cells
Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells
Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation
Alistipes inops sp nov and Coprobacter secundus sp nov., isolated from human faeces
Aliskiren and L-arginine treatments restore depressed baroreflex sensitivity and decrease oxidative stress in renovascular hypertension rats
Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis
Alismanoid A, an unprecedented 1,2-seco bisabolene from Alisma orientale, and its protective activity against H2O2-induced damage in SH-SY5Y cells
Alismanin A, a Triterpenoid with a C-34 Skeleton from Alisma orientale as a Natural Agonist of Human Pregnane X Receptor
Aliskiren Improves Ischemia- and Oxygen Glucose Deprivation-Induced Cardiac Injury through Activation of Autophagy and AMP-Activated Protein Kinase
Aliskiren for heart failure: a systematic review and meta-analysis of randomized controlled trials
Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system
Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus
Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells
Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga
阿里斯托芬政治喜剧中的悲剧意味——以《骑士》为例
Aliskiren Regulates Neonatal Fc Receptor and IgG Metabolism with Attenuation of Anti-GBM Glomerulonephritis in Mice
Alisol A 24-Acetate, a Triterpenoid Derived from Alisma orientale, Inhibits Ox-LDL-Induced Phenotypic Transformation and Migration of Rat Vascular Smooth Muscle Cells through Suppressing ERK1/2 Signaling
Aliskiren attenuates the effects of interleukin-6 on endothelial nitric oxide synthase and caveolin-1 in human aortic endothelial cells
Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry
Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice
Aliskiren Ameliorates Renal Inflammation and Fibrosis Induced by Unilateral Ureteral Obstruction in Mice
Aliskiren reduces albuminuria and oxidative stress, and elevates glomerular filtration rates in Japanese patients with advanced diabetic nephropathy
Aliskiren in Combination with Losartan Reduces Albuminuria Independent of Baseline Blood Pressure in Patients with Type 2 Diabetes and Nephropathy
Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double-Blind Study
Aliskiren Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double-Blind Placebo-Controlled Trial
Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells
Aliskiren Monotherapy Does Not Cause Paradoxical Blood Pressure Rises Meta-Analysis of Data From 8 Clinical Trials
Aliskiren-Induced Chyloperitoneum in a Patient on Peritoneal Dialysis
Aliskiren-based dual- and triple-combination therapies in high-risk US minority patients with Stage 2 hypertension
Aliskiren Induced Remarkable Hypertriglyceridemia
Aliskiren in Patients with Diabetes: A Systematic Review
Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy